Abstract:BACKGROUND: Endothelial functional disturbance is associated with risk factors of various cardiovascular diseases, mainly showing a decreased production of nitrogen monoxidum or abnormal function. Autologous bone marrow stem cell (BMSC) transplantation for heart repair has a certain effects. However, the effect of transplanted stem cells on vascular endothelial cell function is still unclear in early therapeutic period. OBJECTIVE: To explore the influence of autologous bone marrow mononuclear cells on vascular endothelial function in patients with myocardial infarction and left heart insufficiency following coronary artery transplantation. DESIGN, TIME AND SETTING: The opening clinical study was performed at the Institute of Department of Cardiology, Third Hospital, Peking University from January 2005 to December 2006. PARTICIPANTS: Sixteen patients with anterior myocardial infarction, who underwent reperfusion treatment and intracoronary stent at the Third Hospital, Peking University, were enrolled in this study. All patients aged 33-75 years old were divided into a cell transplantation group (n =8) and a control group (n=8) according to patient’s will. METHODS: Patients in both groups were subjected to standard percutaneous coronary intervention (PCI) and medical therapy. Subsequently, autologous bone marrow was collected from patients of the cell transplantation group. Bone marrow mononuclear stem cells were harvested using the density gradient centrifugation. Cell suspension (12.84±4.10) mL was infused into the coronary artery via a catheter, about (1.36±0.44)×109 cells. CD34+ cells were (17.75±8.21)×106 using a flow cytometry. Venous blood was harvested from patients of both groups before and after transplantation to prepare plasma samples. MAIN OUTCOME MEASURES: Changes in nitric oxide, von Willebrand disease factor and prostacyclin-2 levels in plasma were measured before and after transplantation. RESULTS: Compared with the control group, plasma nitric oxide concentration was significantly increased in the cell transplantation group at 24 and 72 hours following transplantation (P =0.015, P =0.03). No significant differences in plasma von Willebrand disease factor and prostacyclin-2 levels were detected (P > 0.05). CONCLUSION: Autologous bone marrow mononuclear cell transplantation via the coronary artery can elevate plasma nitric oxide concentration and does not affect plasma von Willebrand disease factor and prostacyclin-2 levels. This therapy can improve diastolic function of the vascular endothelium and does not impair the endothelial function.

Autologous bone marrow mononuclear cell transplantation improves vascular endothelial function in patients with myocardial infarction and left ventricular dysfunction